ARCHIVES

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

New SEER RFP Sees cheaper Way To Get Data

July 29, 1977

Longmire Reappointed To Cancer Panel

April 8, 1988

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

March 28, 2014

House Appropriations For NCI Identical (So Far) To White House Request; Slight Increase for NIH

June 24, 1988

House Launches Probe of NCI Spending On Cancer Communications, Education

April 12, 2013

NCI Makes Its Pitch To OMB For Its First Billion Dollar Budget; Research Areas Listed By Priority

October 14, 1977